Abstract
Oxidative stress including DNA oxidation is implicated in Parkinson’s disease (PD). We postulated that DNA repair enzymes such as 8-oxoguanosine DNA glycosylase (OGG1) are involved in the PD process. We performed immunohistochemical and biochemical studies on brains of patients with PD and those of patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) as disease controls, and control subjects. We found higher expression levels of mitochondrial isoforms of OGG1 enzymes in the substantia nigra (SN) in cases of PD. Furthermore, Western blot analysis revealed high OGG1 levels in the SN of the patients with PD. Our results indicate the importance of oxidative stress within the susceptible lesions in the pathogenesis of PD.
Similar content being viewed by others
References
Alam ZI, Jenner A, Daniel SE, Lee AJ, Cairns N, Marsden CD, Jenner P, Halliwell B (1997) Oxidative DNA damage in the parkinsonian brain: an apparent selective increased in 8-hydroxyguanine level in substantia nigra. J Neurochem 69:1196–1203
Albers DS, Augood SJ (2001) New insights into progressive supranuclear palsy. Trends Neurosci 24:347–353
Albers DS, Augood SJ, Park LC, Browne SE, Martin DM, Adamson J, Hutton M, Standaert DG, Vonsattel JP, Gibson GE, Beal MF (2000) Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. J Neurochem 74:878–881
Arai K, Morishita K, Shinmura K, Kohno T, Kim SR, Nohmi T, Taniwaki M, Ohwada S, Yokota J (1997) Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene 14:2857–2861
Bohr VA, Stevnsner T, Souza-Pinto NC de (2002) Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 286:127–134
Castellani R, Smith MA, Richey PL, Kalaria R, Gambetti P, Parry G (1995) Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res 696:268–271
De Souza-Pinto NC, Hogue BA, Bohr VA (2001) DNA repair and aging in mouse liver: 8-oxodG glycosylase activity increase in mitochondrial but not in nuclear extracts. Free Radic Biol Med 30:916–923
Dickson DW (1999) Neuropathogenic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246 Suppl 2:II/6–15
Dobson AW, Xu Y, Kelley MR, LeDoux SP, Wilson GL (2000) Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria. J Biol Chem 275:37518–37523
Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112:1171–1192
Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson’s disease. Ann Neurol 30:563–571
Hayakawa M, Torii K, Sugiyama S, Tanaka M, Ozawa T (1991) Age-associated accumulation of 8-hydroxyguanosine mitochondrial DNA of human diaphragm. Biochem Biophys Res Commun 179:1023–1029
Hayakawa M, Hattori K, Sugiyama S, Ozawa T (1992) Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun 189:979–985
Hill K, Model K, Ryan MT, Dietmeier K, Martin F, Wagner R, Pfanner N (1998) Tom40 forms the hydrophilic channel of the mitochondria import pore for preprotein. Nature 395:516–521
Kang D, Nishida J, Iyama A, Nakabeppu Y, Furuichi M, Fujiwara T, Sekiguchi M, Takeshige K (1995) Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria. J Biol Chem 270:14659–14665
Lowe J, Lennox G, Leigh PN (1997) Disorders of movement and system degenerations. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology, 6th edn. Arnold, London, pp 281-343
Malessa S, Gaymard B, Rivaud S, Cervera P, Hirsch E, Verny M, Duyckaerts C, Agid Y, Pierrot-Deseilligny C (1994) Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study. Neurology 44:716–721
Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF (1993) Oxidative damage to mitochondrial DNA showed marked age-dependent increases in human brain. Ann Neurol 34:609–616
Michaels ML, Pham L, Cruz C, Miller JH (1991) MutM, a protein that prevents G.C→T.A transversions, is formamidopyrimidine-DNA glycosylase. Nucleic Acids Res 19:3629–3632
Michaels ML, Cruz C, Grollman AP, Miller JH (1992) Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. Proc Natl Acad Sci USA 89: 7022–7025
Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y(1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease. Biochem Biophys Res Commun 163:1450–1455
Mori H, Nishimura M, Namba Y, Oda M (1994) Cortiobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tanges, and its relation to progressive supranuclear palsy. Acta Neuropathol 88:113–121
Nishioka K, Ohtsubo T, Oda H, Fujiwara T, Kang D, Sugimachi K, Nakabeppu Y (1999) Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Bio Cell 10:1637-1652
Rachek LI, Grishko VI, Musiyenko SI, Kelley MR, LeDoux SP Wilson GL (2002) Conditional targeting of the DNA repair enzyme hOGG1 into mitochondria. J Biol Chem 277:44932–44937
Rapaport D, Neupert W (1999) Biogenesis of TOM40, core component of the TOM complex of mitochondria. J Cell Biol 146:321–331
Richter C, Park JW, Ames BN (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85: 6465–6467
Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet I:1269
Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54:823–827
Shimura-Miura H, Hattori N, Kang D, Miyako K, Nakabeppu Y, Mizuno Y (1999) Increased 8-oxo-dGTPase in the mitochondria of substantia nigra neurons in Parkinson’s disease. Ann Neurol 46:920–924
Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP Jr, Wooten GF, Parker WD (2000) Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem 75:1681–1684
Tajiri T, Maki H, Sekiguchi M (1995) Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat Res 336:257–267
Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson’s disease. Proc Natl Acad Sci USA 93:2696–2701
Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ (1999) Parkinson’s disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 154:1423–1429
Acknowledgement
The authors thank Dr. Makiko Iijima for the technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukae, J., Takanashi, M., Kubo, Si. et al. Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson’s disease and related neurodegenerative disorders. Acta Neuropathol 109, 256–262 (2005). https://doi.org/10.1007/s00401-004-0937-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-004-0937-9